Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norihisa Nitta

Showing results (81-90 of 122) with videos related to

Pageof 13
Sort By:
Oncology|June 17, 2011
Time-course studies of implanted rabbit VX2 liver tumors to identify the appropriate time for starting hepatic arterial embolization in animal modelsAkinaga Sonoda, Norihisa Nitta, Ayumi Nitta-Seko, et al.
Radiation Medicine|January 10, 2009
Ultra-low-dose computed tomography system with a flat panel detector: assessment of radiation dose reduction and spatial and low contrast resolutionYukihiro Nagatani, Norihisa Nitta, Masashi Takahashi, et al.
Experimental and Therapeutic Medicine|October 8, 2014
Asialoerythropoietin ameliorates bleomycin-induced acute lung injury in rabbits by reducing inflammationAkinaga Sonoda, Norihisa Nitta, Keiko Tsuchiya, et al.
Cardiovascular and Interventional Radiology|August 8, 2007
Embolization materials made of gelatin: comparison between Gelpart and gelatin microspheresShinichi Ohta, Norihisa Nitta, Akinaga Sonoda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 13, 2006
[Plasma platinum concentration and anti-tumor effects after intra-arterial infusion of lipiodol-CDDP suspension evaluation with VX 2 rabbit liver cancer model and 7.0 Tesla MRI system]Akinaga Sonoda, Norihisa Nitta, Shinichi Ohta, et al.
Journal of Magnetic Resonance Imaging : JMRI|September 30, 2009
Investigation using an HER-2/neu transgenic mouse model of a newly developed MR contrast agent with the effect of an antitumor drugAkinaga Sonoda, Norihisa Nitta, Shinich Ohta, et al.
Journal of Synchrotron Radiation|August 23, 2006
Refraction contrast 11x-magnified X-ray imaging of large objects by MIRRORCLE-type table-top synchrotronToru Hirai, Hironari Yamada, Makoto Sasaki, et al.
International Journal of Nanomedicine|May 24, 2012
Evaluation of atherosclerotic lesions using dextran- and mannan-dextran-coated USPIO: MRI analysis and pathological findingsKeiko Tsuchiya, Norihisa Nitta, Akinaga Sonoda, et al.
Cardiovascular and Interventional Radiology|May 18, 2011
Comparison of the anti-tumor effects of two platinum agents (miriplatin and fine-powder cisplatin)Shobu Watanabe, Norihisa Nitta, Shinichi Ohta, et al.
International Journal of Nanomedicine|August 17, 2011
Histological study of the biodynamics of iron oxide nanoparticles with different diametersKeiko Tsuchiya, Norihisa Nitta, Akinaga Sonoda, et al.
Pageof 13

Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Oncology|June 17, 2011
Time-course studies of implanted rabbit VX2 liver tumors to identify the appropriate time for starting hepatic arterial embolization in animal modelsAkinaga Sonoda, Norihisa Nitta, Ayumi Nitta-Seko, et al.
Radiation Medicine|January 10, 2009
Ultra-low-dose computed tomography system with a flat panel detector: assessment of radiation dose reduction and spatial and low contrast resolutionYukihiro Nagatani, Norihisa Nitta, Masashi Takahashi, et al.
Experimental and Therapeutic Medicine|October 8, 2014
Asialoerythropoietin ameliorates bleomycin-induced acute lung injury in rabbits by reducing inflammationAkinaga Sonoda, Norihisa Nitta, Keiko Tsuchiya, et al.
Cardiovascular and Interventional Radiology|August 8, 2007
Embolization materials made of gelatin: comparison between Gelpart and gelatin microspheresShinichi Ohta, Norihisa Nitta, Akinaga Sonoda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 13, 2006
[Plasma platinum concentration and anti-tumor effects after intra-arterial infusion of lipiodol-CDDP suspension evaluation with VX 2 rabbit liver cancer model and 7.0 Tesla MRI system]Akinaga Sonoda, Norihisa Nitta, Shinichi Ohta, et al.
Journal of Magnetic Resonance Imaging : JMRI|September 30, 2009
Investigation using an HER-2/neu transgenic mouse model of a newly developed MR contrast agent with the effect of an antitumor drugAkinaga Sonoda, Norihisa Nitta, Shinich Ohta, et al.
Journal of Synchrotron Radiation|August 23, 2006
Refraction contrast 11x-magnified X-ray imaging of large objects by MIRRORCLE-type table-top synchrotronToru Hirai, Hironari Yamada, Makoto Sasaki, et al.
International Journal of Nanomedicine|May 24, 2012
Evaluation of atherosclerotic lesions using dextran- and mannan-dextran-coated USPIO: MRI analysis and pathological findingsKeiko Tsuchiya, Norihisa Nitta, Akinaga Sonoda, et al.
Cardiovascular and Interventional Radiology|May 18, 2011
Comparison of the anti-tumor effects of two platinum agents (miriplatin and fine-powder cisplatin)Shobu Watanabe, Norihisa Nitta, Shinichi Ohta, et al.
International Journal of Nanomedicine|August 17, 2011
Histological study of the biodynamics of iron oxide nanoparticles with different diametersKeiko Tsuchiya, Norihisa Nitta, Akinaga Sonoda, et al.
Pageof 13